RxDoctor Payments Data

Melissa Vallarta

Family · Laredo, TXNPI 1760195127

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,043, 4.1 times the $253 reported in 2023.

$2,172in general payments, 2019–2025

Across 122 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$369
  • Novo Nordisk$346
  • Lilly USA, LLC$284
  • Madrigal Pharmaceuticals$213
  • Amgen$166
  • Boehringer Ingelheim$142
  • plus $652 from 16 others

What the payments were for

  • Food & beverage$2,16099%
  • Education$111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,172 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Laredo

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →